ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2021)
Historic Share-based Compensation for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $411737.0.
- ENDRA Life Sciences' Share-based Compensation fell 2419.04% to $411737.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year decrease of 3128.78%. This contributed to the annual value of $571924.0 for FY2024, which is 4260.27% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Share-based Compensation is $411737.0, which was down 2419.04% from $327799.0 recorded in Q3 2021.
- Over the past 5 years, ENDRA Life Sciences' Share-based Compensation peaked at $546040.0 during Q2 2020, and registered a low of $29698.0 during Q1 2017.
- Its 5-year average for Share-based Compensation is $365859.5, with a median of $365571.5 in 2018.
- Examining YoY changes over the last 5 years, ENDRA Life Sciences' Share-based Compensation showed a top increase of 297206.67% in 2017 and a maximum decrease of 6204.24% in 2017.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Share-based Compensation stood at $402443.0 in 2017, then decreased by 23.53% to $307750.0 in 2018, then increased by 23.23% to $379247.0 in 2019, then surged by 43.21% to $543120.0 in 2020, then dropped by 24.19% to $411737.0 in 2021.
- Its Share-based Compensation was $411737.0 in Q4 2021, compared to $327799.0 in Q3 2021 and $383087.0 in Q2 2021.